India

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Fierce Pharma

India reserves right to act on drug patents after Novartis case

India reserves right to act on drug patents after Novartis case

Reuters

India's top court rebuffs Merck, lets generic Januvia roll out

India's top court rebuffs Merck, lets generic Januvia roll out

Fierce Pharma

U.S. trade office reviewing India's Supreme Court drug ruling

U.S. trade office reviewing India's Supreme Court drug ruling

Reuters

Will Novartis decision impact U.S. drug prices?

Will Novartis decision impact U.S. drug prices?

Marketwatch

Will This Court Decision Be a Thorn in the Side of Novartis?

Will This Court Decision Be a Thorn in the Side of Novartis?

Wall St. Cheat Sheet

Novartis loses landmark India patent case on Glivec

Novartis loses landmark India patent case on Glivec

Reuters

Big Pharma in nervous wait for India verdict on Glivec patent

Big Pharma in nervous wait for India verdict on Glivec patent

Reuters

BDR Pharma seeks India license for Bristol-Myers drug

BDR Pharma seeks India license for Bristol-Myers drug

Reuters

Drug Deficit Turning India’s Claris Into Target: Real M&A

Drug Deficit Turning India’s Claris Into Target: Real M&A

Bloomberg